Evaluation Of Thyroid Function In A Group Of Recently Diagnosed Patients With Thyroid Diseases Followed Up At The Endocrinology Outpatient Clinic Of The University Of Ribeirao Preto (Unaerp)- Sao Paulo, Brazil
<p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 150%; margin: 0in -.1in .0001pt -.1in;"><strong><span style="mso-bidi-font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">Introduction</span></strong><strong><span style="font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">: </span></strong><span style="font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">The determination of thyroid dysfunction is part of the clinical investigation in different medical specialties. Non-thyroid disorders, certain medications and age may affect the hormonal results. The presence of anti-TSH or anti-thyroid hormone antibodies may result in abnormal findings. </span></p> <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 150%; margin: 0in -.1in .0001pt -.1in;"><strong><span style="mso-bidi-font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">Objective</span></strong><strong><span style="font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">:</span></strong><span style="font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';"> To evaluate thyroid function parameters in a wgroup of subjects with recently diagnosed and untreated thyroid disease taking no medication. </span></p> <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 150%; margin: 0in -.1in .0001pt -.1in;"><strong><span style="mso-bidi-font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">Cases</span></strong><strong><span style="font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">: </span></strong><span style="font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">The study was conducted on 301 patients of both sexes, 275 of them non-pregnant women (91.3%) aged 18 to 87 years and 26 of them men (8.7%) aged 21 to 85 years. The subjects were compared to 166 control patients with no thyroid disorders, 123 of them women (75.3%) aged 18 to 81 years and 43 of them men (24.7%) aged 19 to 66 years. The patients were divided into the following groups: Group A-Control Patients; Group B-Subclinical Hypothyroidism; Group C-Clinical Hypothyroidism; Group D-Subclinical Hyperthyroidism; Group E-Clinical Hyperthyroidism; Group F-Chronic Thyroiditis; Group G-Goiter; Group H-Papilliferous Carcinoma; Group I-Previous Hyperthyroidism. </span></p> <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 150%; margin: 0in -.1in .0001pt -.1in;"><strong><span style="mso-bidi-font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">Results</span></strong><strong><span style="font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">:</span></strong><span style="font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';"> The female sex was preponderant in all groups, with no males occurring in the Clinical Hyperthyroidism, Papilliferous Carcinoma or Previous Hyperthyroidism groups. Patients with Subclinical Hyperthyroidism and Goiter belonged to significantly older age ranges. Mean TSH values were higher in the Clinical and Subclinical Hyperthyroidism Groups. Free T4 and T3 levels were significantly lower in Clinical Hypothyroidism and significantly higher in Clinical Hyperthyroidism. Mean Thyroglobulin levels were significantly higher in the Goiter Group and mean Anti-Thyroglobulin antibody (Anti-Tg) and Anti-Thyroperoxidase (Anti-TPO) levels were significantly higher in the Chronic Thyroiditis group. The Anti-TSH receptor (TRAB) antibody was significantly higher in the Clinical Hyperthyroidism Group and the finding of Toxic Multinodular Goiter predominated in the Subclinical Hyperthyroidism Group. </span></p> <p>Â </p> <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 150%; margin: 0in -.1in .0001pt -.1in;"><strong><span style="mso-bidi-font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">Conclusion</span></strong><strong><span style="font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">: </span></strong><span style="font-size: 10.0pt; line-height: 150%; font-family: 'Cambria','serif'; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman';">Autoimmune thyroid disorders predominated among females and in the less advanced age ranges and structural thyroid disorders and high level of thyroglobulin predominated in the more advanced age ranges.</span></p>
Introduction
The thyroid gland is the first endocrine gland arising in the human embryo, presenting a highly organized structure and able to synthesize and store its secretion products, i.e., the thyroid hormones (TH) triiodothyronine (T3) and thyroxine (T3), important for the development, growth and maintenance of the quality of life of human beings. Checking for thyroid dysfunctions is part of the clinical investigation in various medical specialties. In general, thyroid function tests can be interpreted in a simple and direct manner [1, 2]. Non-thyroid diseases, pregnancy [3], some medications (mainly amiodarone and lithium) [4, 5, 6] and age [7] can affect extra-thyroid metabolism and the transport, absorption and/or action of thyroid hormones, mimicking dysfunction of this gland [8, 9, 10, 11]. The presence of anti-TSH or anti-TH antibodies may result in abnormal findings [12]. The synthetic and secretory activity of the thyroid is basically stimulated or controlled by pituitary thyrotropin (TSH) and involves the presence of iodine and thyroglobulin (Tg) which is responsible for 70 to 80% of the entire protein content of this gland. Thyroglobulin (Tg) is a glycoprotein whose levels are increased in almost patients with differentiated thyroid cancer, subacute thyroidits and endemic goiter, representing a maker of thyroid disease. The involvement of the thyroid by agents that induce a granulomatous and nonspecific inflammatory reaction causes thyroiditis, which is classified as acute, subacute and chronic. Hashimoto’s thyroiditis is associated with an increase in antithyroperoxidase (anti-TPO) and/or anti-thyroglobulin (anti-Tg) antibody titers. It is characterized by a diffuse enlargement of the thyroid and is the main cause of acquired hypothyroidism. Hyperthyroidism is a syndrome due to increased TH synthesis and secretion by the thyroid, with Graves’ disease (autoimmune) being the more frequent form which courses with elevated titers of anti-TPO, anti-Tg and TRAB (anti-TSH receptor antibody), accompanying or not to the development of Alves MLD. Evaluation of Thyroid Function in a Group of Recently Diagnosed Patients with Thyroid Diseases Followed up at the Endocrinology Outpatient Clinic of the University of Ribeirão Preto (Unaerp) - São Paulo, Brazil. J Endocrinol 2017, 1(1): 000102.
ophthalmopathy. Cancer of the thyroid is the most frequent among endocrine tumors, with the papilliferous tumor representing up to 88.5% of cases.
Objective
To evaluate thyroid function parameters in a group of patients with recently diagnosed and still untreated thyroid disease, taking no medication and followed up at the Endocrinology outpatient clinic of the University of Ribeirão Preto- UNAERP, São Paulo, Brazil.
Cases and Methods
The study was conducted on 306 patients of both sexes, not taking amiodarone, lithium,biotin and corticosteroid, 279 of them non-pregnant women (91.3%) ranging in age from 18 to 87 years and 27 of them men (8.7%) ranging in age from 21 to 85 years. The subjects were compared to 167 control patients (with no thyroid disorder diagnosed upon investigation and followed up at this service due to another type of endocrine disease- dyslipidemia, obesity, pre bariatric surgery- and not taking any medicine), 123 of them women (75.3%) ranging in age from 18 to 81 years and 44 of them men (24.7%) ranging in age from 19 to 66 years. The study was approved by the Ethics Committee of UNAERP (“Plataforma Brasil” Protocol: 27031207) and all patients gave written informed consent to participate. All subjects were submitted to the determination of TSH, Free T4, Free T3, Tg, Anti-TPO, Anti-Tg, and TRAB, to ultrasound (US) examination in cases of diffuse or nodular goiter, and to Fine Needle Aspiration Biopsy (FNAB) in cases of nodular disease. No patient with Graves’ disease had clinical ophthalmopathy. All measurements were made by electrochemoluminescence using the following normal reference values for adults: 0.27 to 4.5 µIU/ml TSH, 0.8 to 1.9 ng/dl Free T4, 2.0 to 4.4 ng/ml Free T3, 1.4 to 78 ng/ml Thyroglobulin, < 34 IU/ml Anti-TPO, <116 IU/ml Anti-Tg, and <1.75 IU/L TRAB [7, 8] . US examination was performed using a Samsung-Medison 8000 EX apparatus Copyright© Alves MLD.
(Samsung Medison Co., Seoul, Korea). FNAB was performed on an ambulatory basis and the material obtained was examined after staining with hematoxylin- eosin.
The patients were divided into 9 groups according to their diagnosis
Group A-Control Patients
Group B- Subclinical Hypothyroidism (Elevated Tsh – Normal T3 and T4) [13]
Group C-Clinical Hypothyroidism [14, 15, 16]
Group D-Subclinical Hyperthyroidism (Reduced Tsh, Normal T3 and T4) [13]
Group E-Clinical Hyperthyroidism [17]
Group F-Chronic Thyroiditis [18]
Group H-Carcinoma (Papilliferous) [20]
Results
The results obtained in the present study were analyzed statistically by the two-tailed MANN-WHITNEY test and by the DUNNETT test and are listed in (Tables 1-3). The female sex was preponderant in all groups, with no males occurring in the Clinical Hyperthyroidism, Carcinoma (Papilliferous) or Previous Hyperthyroidism groups. Patients with Subclinical Hyperthyroidism and Goiter belonged to significantly older age ranges compared to the remaining groups (p<0.0001). Mean TSH values were higher in the Clinical Hypothyroidism and Chronic Thyroiditis groups and were lower in the Clinical and Subclinical Hyperthyroidism group. Free T4 and Free T3 values were significantly lower in the Clinical Hypothyroidism group and significantly higher in the Clinical Hyperthyroidism group (p<0.0001). Mean Tg values were significantly higher among patients with Goiter and Anti-TG and Anti-TPO values were significantly higher among patients with Chronic Thyroiditis (evaluations performed before FNAB) (p<0.0001). TRAB levels were significantly higher in the Clinical Hyperthyroidism group (p<0.0001). The detection of Toxic Multinodular Goiter predominated in the Subclinical Hyperthyroidism group.
| M | F | M + F | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Group | 1 | 2 | Total | ||||||
| A | 44 | 123 | 167 | ||||||
| B | 2 | 20 | 22 | ||||||
| C | 1 | 7 | 8 | ||||||
| D | 5 | 16 | 21 | ||||||
| E | 8 | 8 | |||||||
| F | 9 | 70 | 79 | ||||||
| G | 9 | 149 | 159 | ||||||
| H | 4 | 4 | |||||||
| I | 5 | 5 | |||||||
| Total | 71 | 402 | 473 |
Table 1: Characterization of the groups studied according to frequency by sex. M = Male; F - Female
| Group | Sex | N | Minimum | Maximum | Mean | Sd | ||||||||||||||
| A | 1 | 44 | 19 | 66 | 38.8 | 12.6 | ||||||||||||||
| 2 | 123 | 18 | 81 | 39.3 | 14.36 | |||||||||||||||
| B | 1 | 2 | 28 | 73 | 50.5 | 31.82 | ||||||||||||||
| 2 | 20 | 20 | 78 | 50.5 | 14.84 | |||||||||||||||
| C | 1 | 1 | 41 | 41 | 41 | - | ||||||||||||||
| 2 | 7 | 20 | 84 | 39.7 | 25.26 | |||||||||||||||
| D | 1 | 5 | 54 | 85 | 69.6 | 14.43 | ||||||||||||||
| 2 | 16 | 29 | 79 | 56.6 | 18.41 | |||||||||||||||
| E | 1 | - | - | - | - | - | ||||||||||||||
| 2 | 8 | 21 | 65 | 41.3 | 17.29 | |||||||||||||||
| F | 1 | 9 | 21 | 72 | 47.6 | 16.3 |
Table 2: Characterization of the groups studied according to frequency by sex. M = Male; F - Female
| 2 | 70 | 18 | 87 | 43.4 | 15.7 | |
|---|---|---|---|---|---|---|
| G | 1 | 10 | 44 | 70 | 55.6 | 10.2 |
| 2 | 149 | 18 | 84 | 54.2 | 15.3 | |
| H | 1 | - | - | - | - | - |
| 2 | 4 | 23 | 63 | 42.5 | 16.4 | |
| I | 1 | - | - | - | - | - |
| 2 | 5 | 46 | 82 | 55,6 | 15,1 |
Table 3: Characterization of the groups studied according to frequency by sex. M = Male; F - Female
- Mean Values Of The Indicators Per Group
- Groups Mean Age (Years)
- Tsh (µiu/Ml) Free T4
- (Ng/Ml) Free T3 (Pg/Ml) Tg (Ng/Ml) Antitg (Iu/Ml) Antitpo (Iu/Ml) Trab (Iu/L)
- A
- 39.2
- 1.2
- 1.11
- 3.17
- 33.33
- 10.74
- 13.01
- 0.42
- B
- 50.5
- 1.9
- 1.11
- 3.24
- 21.63
- 20.14
- 7.99
- 0.47
- C
- 40,5
- 30.8
- 0.79
- 2.47
- 82.8
- 89.58
- 98.97
- 0.34
- D
- 59.7
- 0.2
- 1.37
- 3.12
- 60.14
- 74.17
- 53.01
- 1.46
- E
- 41.3
- 0
- 3.49
- 8.83
- 44.18
- 192.99
- 172.3
- 9.02
- F
- 43.9
- 6.2
- 1.06
- 2.93
- 38.47
- 294.09
- 223.81
- 0.59
- G
- 54.3
- 2.3
- 1.11
- 2.82
- 46.58
- 27.11
- 22.09
- 0.42
- H
- 42.5
- 6.5
- 1.39
- 3.58
- 5.62
- 7.21
- 8.71
- 0.3
- I
- 55.6
- 2.2
- 1.06
- 2.77
- 29.85
- 216.38
- 165.91
- 0.47
- General
- 46.5
- 3.4
- 1.15
- 3.08
- 39.85
- 74.19
- 58.88
- 0.65
Table 4: Mean Values of the Indicators per Group.
Discussion
The female sex predominated in all groups including the Control Group, indicating that endocrine diseases are preponderant among women or that women seek the help of endocrinologists more frequently. The Clinical Hypothyroidism, Subclinical Hyperthyroidism, Goiter and Previous Hyperthyroidism groups involved the older age ranges, confirming the higher prevalence of these diseases with increasing age. A younger age range predominated in Clinical Hyperthyroidism, a characteristic of autoimmune diseases. The Clinical Hyperthyroidism, Carcinoma (Papilliferous) and Previous Hyperthyroidism groups did not contain any males, indicating the higher prevalence of these endocrine diseases among females. TSH, Free T4 and Free T3 were altered in the Clinical Hypothyroidism (higher TSH and lower T3 and T4) and Clinical Hyperthyroidism (lower TSH and higher T3 and T4) groups, clearly indicating the occurrence of thyroid dysfunction in these diseases with repercussions on pituitary control. The Anti-Thyroid Antibody (Anti-Tg and Anti TPO) findings were significant in the Thyroiditis, Goiter and Previous Hyperthyroidism groups, diseases that course with changes in the thyroid parenchyma.In the Clinical Hyperthyroidism Group – a thyroid disease related to autoimmunity, Anti-TPO, Anti- TG and TRAB were positive, the last one exclusive and a marker of this endocrine disease. There was a small, nonsignificant positivity for TRAB in the Subclinical Hyperthyroidism Group, possibly indicating the presence of patients with Pre-Graves’ disease in this group. Thyroglobulin values were higher in the Goiter Group, possibly indicating structural thyroid changes since there was no interference of aggression to the thyroid parenchyma by the execution of the FNAB procedure before its collection.The Carcinoma (Papilliferous) Group did not show any specific laboratory changes, with its diagnosis being exclusively based on FNAB findings and confirmed by histopathological analysis. During old age, accompanying the regression that occurs in other parts of organism, the volume of the thyroid may reduced, with an increase in connective tissue and a consequent multinodular aspect. Multinodular goiter was more found in our old patients.
Conclusion
The laboratory data obtained in the present study showed that female sex and less advanced age ranges were typical of autoimmune thyroid disease, that structural thyroid diseases and high levels of Thyroglobulin predominated among the more advanced age ranges and that the patients benefited from the evaluation of thyroid function by means of the tests presented, with increased accuracy of diagnosis and treatment of the various thyroid diseases.
Acknowledgments
We are grateful to the ENDOCRINOLOGY LEAGUE of UNAERP- years 2015 and 2016- for participating in data collection for the present study and to UNAERP by the support.
References
-
Gurnell M, Halsall DJ, Chatterine VK (2011) What should be done when thyroid function tests do not make sense? Clin Endocrinol 74(6): 673-678.
-
Cooper DS (2007) The thyroid gland. In: Greespan FS (Eds.) Basic & clinical endocrinology 8th ed. McGraw- Hill pp 209-280.
-
Dufour DR (2007) Laboratory tests of thyroid function: uses and limitations. Endocrinol Metab Clin North Am 36(3): 579-594.
-
Tahboub R, Arafat BM (2009) Sex steroids and the thyroid. Best Pract Res Clin Endocrinol Metab 23(6): 769-780.
-
Danzi S, Klein I (2015) Amiodarone-induced thyroid dysfunction. J Intensive Care Med 30(4): 179-185.
-
Lazarius JH (1998) The effects of lithium therapy on thyroid and thyrotropin- releasing hormone. Thyroid 8(10): 909-913.
-
Faggiano A, Del Prete M, Marciello F, Marotta V, Ramundo V, et al. (2011) Thyroid diseases in elderly. Minerva Endocrinol 36(3): 211-231.
-
Kwok JS, Chan JH, Chan MH (2012) Biotin interference on TSH and free thyroid hormone measurement. Pathology 44(3): 278-280. Alves MLD. Evaluation of Thyroid Function in a Group of Recently Diagnosed Patients with Thyroid Diseases Followed up at the Endocrinology Outpatient Clinic of the University of Ribeirão Preto (Unaerp) - São Paulo, Brazil. J Endocrinol 2017, 1(1): 000102.
-
Dayan CM (2001) Interpretation of thyroid function tests. Lancet 357: 619-624.
-
Salvatore D, Davies TE, Schlumberger MJ, Ian D Hay (2011) Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Larsen PR (Eds). Williams textbook of Endocrinology 12th Philadelphia: WB Saunders Co pp 327-337.
-
Sakata S, Matsuda M, Ogwa T, Hiroshi T, Ikuo M, et al. (1994) Prevalence of thyroid hormone autoantibodies in healthy subjects. Clin Endocrinol 41(3): 365-370.
-
Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, et al. (2005) Subclinical thyroid dysfunction: a joint statement on management from the American Thyroid Association of Clinical Endocrinologists, the American Thyroid Association and Endocrine Society. J Clin Endocrinol Metab 90(1): 581-585.
-
Graf H, Carvalho GA (2002) Fatores interferentes na interpretação de dosagens laboratoriais no diagnóstico do hiper e hipotireoidismo. Arq Bras Endocrinol Metab 46(1): 51-64.
-
Brenta G, Vaisman M, Sgarbi JA, Liliana MB, de Andrada NC, et al. (2013) Clinical practice guidelines for management of hypothyroidism. Arq Bras Endocrinol Met 57(4): 265-291.
-
Okosiene O, Gilbert J, Abrahan P, Boelaert K, Dayan C, et al. (2016) Management of primary hypothyroidism: statement by the British thyroid association executive Committee. Clin Endocrinol 84(6): 799-808.
-
Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of The American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 17(3): 456-520.
-
Sweeny LB, Stewart C, Gaitonde DY (2014) Thyroditis: an integrated approach. Am Fam Physician 90(6): 389-396.
-
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. (2016) 2015 American Thyroid Association Management guidelines for adults patients with thyroid nodules and differentiated Copyright© Alves MLD. thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1): 1-133.
-
Crippa S, Mazzucchelli L, Cibas ES, Ali SZ (2010) The Bethesda System for reporting thyroid fine-needle aspiration specimens. Am J Clin Pathol 134(2): 343- 344. Alves MLD. Evaluation of Thyroid Function in a Group of Recently Diagnosed Patients with Thyroid Diseases Followed up at the Endocrinology Outpatient Clinic of the University of Ribeirão Preto (Unaerp) - São Paulo, Brazil. J Endocrinol 2017, 1(1): 000102.
-
Straccia P, Rossi ED, Bizarro T (2015) A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated? Cancer Cytopathol 123(12): 713-722. Copyright© Alves MLD.
- Shaping Healthy Futures: Pediatric Endocrine Breakthroughs of 2025
- Precision Medicine in Obesity: Customizing Treatment for 2025
- The Thyroid Revolution: How 2025 is Redefining Hormone Health
- Editorial- Targeting Immunometabolism for Generating Innovative Therapies for Cancer
- Current Knowledge of Chickenpox
- Correlation of Preinjection Values of Gonadotropins and Estradiol Level with Clinical and Radiologic Evidence of Sufficient Pubertal Suppression in Girls with Central Precocious Puberty